Biora Therapeutics Inc (NAS:BIOR)
$ 0.678 0.02 (3.04%) Market Cap: 24.73 Mil Enterprise Value: 66.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Q4 2020 Progenity Inc Earnings Call Transcript

Mar 18, 2021 / 08:30PM GMT
Release Date Price: $109.75 (-11.85%)
Operator

Welcome to the Progenity's Fourth Quarter 2020 Earnings Call. (Operator Instructions)

I would now turn the call over to Robert Uhl, Managing Director with Westwicke ICR, Progenity's Investor Relations firm.

Robert Uhl
Westwicke ICR - Managing Director

Thank you, operator. Good afternoon and welcome to Progenity's Fourth Quarter 2020 Financial Results Conference Call. Joining me on the call are Dr. Harry Stylli, Chairman and Chief Executive Officer; and Eric d'Esparbes, Chief Financial Officer.

Before I turn the call over to Dr. Stylli, I would like to remind you that today's call will include forward-looking statements within the meaning of the federal securities laws including but not limited to the types of statements identified as forward-looking in our annual report on Form 10-K that we will file later today and our subsequent periodic reports filed with the SEC, which will all be available on our website in the Investor section.

These forward-looking statements represent our views only as of the date of this call and involve

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot